摘要
近期,来自19个国家的33名具有肝硬化相关并发症管理专业知识的研究人员经过三轮德尔菲法提出了12项有关人血白蛋白在肝硬化相关并发症治疗中应用的国际立场声明。本文对该部国际立场声明的主要内容进行中文摘译。
R ecently,33 investigators from 19 countries with expertise in managing cirrhosis-related complications have proposed 12 international position statements regarding the use of human albumin infusion for cirrhosis-related complications after a three-round Delphi consensus process.This article gives an excerpt of the main contents of this international position statement in Chinese language.
作者
白朝辉
杨永平
杨丽
祁兴顺
BAI Zhaohui;YANG Yongping;YANG Li;QI Xingshun(Department of Gastroenterology,General Hospital of Northern Theater Command,Shenyang,China;Department of Hepatology,The Fifth Medical Center of Chinese PLA General Hospital,Beijing,China;Department of Gastroenterology,West China Hospital,Sichuan University,Chengdu,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2023年第8期1817-1818,共2页
Journal of Clinical Hepatology
关键词
肝硬化
血清白蛋白
人
共识
Liver Cirrhosis
Serum Albumin,Human
Consensus
